SEC Form 4 · accession 0001225208-15-005985
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Warwick Bedwell
Officer — President, Pharma Pkgs Systems
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 3:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2015 | M | 9,458 | $21.22 | A | 45,879 | D | |
| Common Stock | Feb 24, 2015 | M | 8,562 | $20.425 | A | 54,441 | D | |
| Common Stock | Feb 24, 2015 | M | 6,584 | $29.555 | A | 61,025 | D | |
| Common Stock | Feb 24, 2015 | M | 3,617 | $47.34 | A | 64,642 | D | |
| Common Stock | Feb 24, 2015 | S | 3,617 | $53.65 | D | 61,025 | D | |
| Common StockF1 | Feb 24, 2015 | S | 6,584 | $52.7279 | D | 54,441 | D | |
| Common StockF2 | Feb 24, 2015 | S | 8,562 | $52.9994 | D | 45,879 | D | |
| Common StockF1 | Feb 24, 2015 | S | 9,458 | $52.7279 | D | 36,421 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $29.555 | Feb 24, 2015 | M | 6,584 | D | Feb 19, 2014 | Feb 19, 2023 | Common Stock | 6,584 | 13,168 | D |
| Stock Option (Right to Buy) | $21.22 | Feb 24, 2015 | M | 9,458 | D | Feb 21, 2013 | Feb 21, 2022 | Common Stock | 9,458 | 9,458 | D |
| Stock Option (Right to Buy) | $20.425 | Feb 24, 2015 | M | 8,562 | D | Feb 22, 2012 | Feb 22, 2021 | Common Stock | 8,562 | 0 | D |
| Stock Option (Right to Buy) | $47.34 | Feb 24, 2015 | M | 3,617 | D | Feb 24, 2015 | Feb 24, 2024 | Common Stock | 3,617 | 10,848 | D |
Explanation of responses
- F1This was multiple transactions on the same date with prices in the range of $51.905 to $53.65. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
- F2This was multiple 51.95 to $53.65. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.